例如:"NBL1", "4681", "drought"
收藏
6361 CCL17

6361

CCL17

C-C motif chemokine ligand 17

protein-coding

Homo sapiens

基因描述

Type Description
Definition C-C motif chemokine ligand 17

研究结论

Date Results Publications
2021-04-17 13:16:00 Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis. 33670758
2021-04-03 13:37:00 Low serum CCL17 as a marker for severe/critical COVID-19: A pathogenic link. 33581267
2021-04-03 13:29:00 miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid. 32399091
2021-03-28 19:07:00 Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by 33264064
2020-12-05 12:58:00 Thymus and Activation-regulated Chemokine as a Biomarker for IgG4-related Disease. 32265499

名称对应

Type IDs
Synonymous A-152E5.3, ABCD-2, SCYA17, TARC
Gene
UniProtKB-ID: CCL17_HUMAN
UniprotKB: Q92583
UniParc: UPI00001362D9
EMBL: BC112068, AC004382, BC112066, BC069107, D43767, CH471092, EF064767
Ensembl: ENSG00000102970
KO: hsa:6361
Nucleutide sequences
EMBL-CDS: AAI12067.1, EAW82921.1, ABK41950.1, AAI12069.1, BAA07824.1, AAH69107.1, AAC24308.1
Ensembl_TRS: ENST00000616880, ENST00000219244
Protein sequencees
Ensembl_PRO: ENSP00000480147, ENSP00000219244
RefSeq: XP_016879019.1, XP_011521558.1, NP_002978.1
Others
UniRef100: UniRef100_Q92583
UniRef90: UniRef90_Q92583
UniRef50: UniRef50_Q92583
UniGene: Hs.546294
CCDS: CCDS10780.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员